- Home
- PYPD vs IHT Comparison
PYPD vs IHT Comparison
Compare PYPD & IHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- IHT
- Stock Information
- Founded
- PYPD 2008
- IHT 1971
- Country
- PYPD Israel
- IHT United States
- Employees
- PYPD N/A
- IHT N/A
- Industry
- PYPD Medical/Dental Instruments
- IHT Investment Bankers/Brokers/Service
- Sector
- PYPD Health Care
- IHT Finance
- Exchange
- PYPD Nasdaq
- IHT Nasdaq
- Market Cap
- PYPD 16.5M
- IHT 18.0M
- IPO Year
- PYPD 2020
- IHT N/A
- Fundamental
- Price
- PYPD $3.22
- IHT $2.28
- Analyst Decision
- PYPD Strong Buy
- IHT
- Analyst Count
- PYPD 2
- IHT 0
- Target Price
- PYPD $12.00
- IHT N/A
- AVG Volume (30 Days)
- PYPD 29.2K
- IHT 2.5K
- Earning Date
- PYPD 02-12-2025
- IHT 12-31-2024
- Dividend Yield
- PYPD N/A
- IHT 0.88%
- EPS Growth
- PYPD N/A
- IHT N/A
- EPS
- PYPD N/A
- IHT N/A
- Revenue
- PYPD N/A
- IHT $7,692,305.00
- Revenue This Year
- PYPD N/A
- IHT N/A
- Revenue Next Year
- PYPD N/A
- IHT N/A
- P/E Ratio
- PYPD N/A
- IHT N/A
- Revenue Growth
- PYPD N/A
- IHT 4.55
- 52 Week Low
- PYPD $2.37
- IHT $1.22
- 52 Week High
- PYPD $9.20
- IHT $2.36
- Technical
- Relative Strength Index (RSI)
- PYPD 53.21
- IHT 59.17
- Support Level
- PYPD $2.37
- IHT $2.06
- Resistance Level
- PYPD $3.13
- IHT $2.24
- Average True Range (ATR)
- PYPD 0.32
- IHT 0.13
- MACD
- PYPD 0.05
- IHT -0.00
- Stochastic Oscillator
- PYPD 64.89
- IHT 100.00
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About IHT InnSuites Hospitality Trust Shares of Beneficial Interest
InnSuites Hospitality Trust is a real estate investment trust. It is engaged in the ownership and operation of hotel properties. It owns and operates hotels, provides management services for hotels, and also provides trademark license services. The Trust is also involved in various operations incidental to the operation of hotels, such as the operation of restaurants, meeting/banquet room rentals, and the operation of a reservation system. It has one reportable segment Hotel Operations & Hotel Management Services.